CSI Market
Sign In | Register

Xortx Therapeutics inc (XRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XRTX Annual Balance Sheets →
Balance sheet data covering Xortx Therapeutics inc–Dec 31 2024 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents0.86
Cash & Short-term Investments0.00
Accounts receivable0.08
Other Current Assets0.32
Total Current Assets1.26
Intangible AssetsAnd Goodwill0.19
Total Assets2.68
Liabilities
Total Current Liabilities0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.60
Total Liabilities0.60
Stockholders' Equity
Common Stockholder's Equity2.08
Total Stockholder's Equity2.08
Liabilities & Stockholder's Equity2.68
4 historic quarters locked

Sign in to unlock the full Xortx Therapeutics inc balance sheet history.

Sign In Create Free Account

About Xortx Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-032775

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.